These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20835551)

  • 21. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
    Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
    Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
    Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
    Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA; Bashandy MA; Abdou AG; Zahran AA
    Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
    Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
    APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.
    Song Q; Wang D; Lou Y; Li C; Fang C; He X; Li J
    Diagn Pathol; 2011 Dec; 6():126. PubMed ID: 22188859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
    Omar E; Madhavan M; Othman NH
    Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
    Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
    Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma.
    Miki H; Kitaichi M; Masuda E; Komaki K; Yamamoto Y; Monden Y
    J Surg Oncol; 1999 Jun; 71(2):76-81; discussion 81-2. PubMed ID: 10389862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
    Sakr HI; Chute DJ; Nasr C; Sturgis CD
    Diagn Pathol; 2017 Oct; 12(1):71. PubMed ID: 28974238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions.
    He X; Wei Q; Zhang X; Xiao J; Jin X; Zhu Y; Cui B; Ning G
    Pathol Res Pract; 2010 Oct; 206(10):712-5. PubMed ID: 20646838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.
    Diaz NM; Mazoujian G; Wick MR
    Arch Pathol Lab Med; 1991 Dec; 115(12):1203-7. PubMed ID: 1768209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.
    Vasko VV; Gaudart J; Allasia C; Savchenko V; Di Cristofaro J; Saji M; Ringel MD; De Micco C
    Eur J Endocrinol; 2004 Dec; 151(6):779-86. PubMed ID: 15588246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
    Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
    Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.